Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

ELVN holding history

Enliven Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings

Shares (Q2 2026)
10,025,017
Value
$508.8M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ELVN by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,025,017$508.8M<0.1%+3,195,771+46.8%AddedHolders
Q1 20266,829,246$267.7M<0.1%−278,389−3.9%ReducedHolders
Q4 20257,107,635$109.5M<0.1%−21,561−0.3%ReducedHolders
Q3 20257,129,196$145.9M<0.1%−430,705−5.7%ReducedHolders
Q2 20257,559,901$151.7M<0.1%+950,372+14.4%AddedHolders
Q1 20256,609,529$130.1M<0.1%+113,658+1.7%AddedHolders
Q4 20246,495,871$146.2M<0.1%+199,692+3.2%AddedHolders
Q3 20246,296,179$160.8M<0.1%+601,611+10.6%AddedHolders
Q2 20245,694,568$133.1M<0.1%−551,725−8.8%ReducedHolders
Q1 20246,246,293$109.9M<0.1%+1,085,051+21.0%AddedHolders
Q4 20235,161,242$71.4M<0.1%+1,485,029+40.4%AddedHolders
Q3 20233,676,213$50.2M<0.1%−325,398−8.1%ReducedHolders
Q2 20234,001,611$81.7M<0.1%+838,129+26.5%AddedHolders
Q1 20233,163,482$69.3M<0.1%+3,068,137+3,217.9%AddedHolders
Q4 202295,345$390.0K<0.1%+95,345NewHolders
Q2 20220$00.0%−370,159−100.0%Sold outHolders
Q1 2022370,159$696.0K<0.1%−1,639,995−81.6%ReducedHolders
Q4 20212,010,154$4.52M<0.1%−300,536−13.0%ReducedHolders
Q3 20212,310,690$9.43M<0.1%−335,241−12.7%ReducedHolders
Q2 20212,645,931$20.9M<0.1%+399,389+17.8%AddedHolders
Q1 20212,246,542$19.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.